Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

This study provides information about clinical and demographic factors associated with retention rates of bDMARDs from a real-life, single-center cohort of PsA patients.PMID:37462129 | DOI:10.4081/reumatismo.2023.1544

Source: Reumatismo - July 18, 2023 Category: Rheumatology Authors: M Ferrito G Cincinelli M Manara R Di Taranto E G Favalli R Caporali Source Type: research